{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:43:20Z","timestamp":1789699400539,"version":"4.0.1"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/jcp.0b013e3182524293","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T09:43:35Z","timestamp":1335519815000},"page":"398-402","source":"Crossref","is-referenced-by-count":27,"title":["Open-Label Treatment With Olanzapine for Patients With Borderline Personality Disorder"],"prefix":"10.1097","volume":"32","author":[{"given":"Mary C.","family":"Zanarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Charles","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holland","family":"Detke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Deberdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Fitzmaurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Corya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210128","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1192\/bjp.bp.107.037903","article-title":". Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study.","volume":"193","author":"Schulz","year":"2008","journal-title":"Br J Psychiatry"},{"key":"R3-15-20210128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1521\/pedi.17.3.233.22147","article-title":". Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology.","volume":"17","author":"Zanarini","year":"2003","journal-title":"J Pers Disord"},{"key":"R4-15-20210128","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4088\/JCP.v65n0118","article-title":"Olanzapine versus placebo in the treatment of borderline personality disorder.","volume":"65","author":"Bogenschutz","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R5-15-20210128","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4088\/JCP.v62n1103","article-title":"Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study.","volume":"62","author":"Zanarini","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R8-15-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects.","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"4","key":"R9-15-20210128","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0269881103174013","article-title":"The Barnes Akathisia Rating Scalerevisited.","volume":"17","author":"Barnes","year":"2003","journal-title":"J Psychopharmacol"},{"issue":"5","key":"R12-15-20210128","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/0269881110370505","article-title":"Weight changes over time in adults treated with the oral or depot formulations of olanzapine: a pooled analysis of 86 clinical trials.","volume":"25","author":"Millen","year":"2011","journal-title":"J Psychopharmacol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e3182524293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:59:42Z","timestamp":1620957582000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201206000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182524293","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}